Gilde Healthcare leads £6 million ($9.4 million) financing round of Digital Health company Qinec - Gilde Healthcare

Gilde Healthcare leads £6 million ($9.4 million) financing round of Digital Health company Qinec

9. Juni 2015

London – Qinec, a pioneer in Personalized Healthcare Management, today announced that it has secured £6 million in Series B funding, led by Gilde Healthcare. Existing investors Amadeus Capital Partners and Archimedia participated as well.

Qinec will use the funding to scale the team and further expand within a Healthcare IT market segment predicted to be worth over $1.3 billion.

Qinec, which counts Alliance Medical and Optegra Eye Health Care amongst its customers, uses real-time data to personalize the patient journey resulting in optimal outcomes for patients, providers and payers whilst simultaneously reducing cost. Its cloud-based Software as a Service (SaaS) platform today supports millions of patient journeys a year across Europe.

As part of the investment, Janke Dittmer, partner at Gilde Healthcare, joins the Board as a Non-Executive Director and Erik Masing as an Advisor. Additionally, Qinec is strengthening its executive team with the introduction of Andrew Wyatt as Chief Operating Officer. Andrew brings a depth of experience in successfully scaling software and SaaS businesses, including BroadSoft Inc (NASDAQ: BSFT) where he was VP Strategy and Apertio Ltd where he was Chief Product Operations Officer and interim CEO.

About Qinec
Qinec is a UK-based digital health company providing Personalized Healthcare Management (PHM) solutions. The company’s cloud-based SaaS platform uses real time data to orchestrate the patient journey to achieve optimal outcomes for patients, providers and payers at lower cost.
Managing millions of patients a year across Europe, Qinec tailors processes and optimizes clinical and administrative workflows across every specialty of outpatient care. For more information about Qinec please visit www.qinec.com.

About Gilde Healthcare
Gilde Healthcare (Utrecht, The Netherlands and Cambridge, Massachusetts, US) is a private equity investor focused on fast growing healthcare businesses. It manages €550 million across two business lines. The Gilde Healthcare Technology funds target companies developing home & digital health solutions, medical devices and therapeutics in Europe and the US. The Gilde Healthcare Services funds focus on healthcare service providers, such as specialist clinics, elderly care, primary care and other service providers in the Benelux and Germany.
For a list of Gilde’s portfolio companies please visit the website at www.gildehealthcare.com.

Gilde Healthcare company Moximed raises $40 Million to advance world’s first Implantable Shock Absorber for Knee Osteoarthritis

Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced $40 million in Series C equity and debt financing. The round was led...
16. August 2022

Gilde Healthcare company Nalu appoints Thomas West as new president and CEO

Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced that the Board of Directors has appointed Thomas “Tom” West as President and Chief Executive Officer....
19. Juli 2022

Gilde Healthcare bolsters its Private Equity team in Frankfurt office

Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV. With the recruitment...
12. Juli 2022